Janoff, US
Andrew Janoff, Yardley, PA US
Patent application number | Description | Published |
---|---|---|
20080199515 | FIXED DRUG RATIOS FOR TREATMENT OF HEMATOPOIETIC CANCERS AND PROLIFERATIVE DISORDERS - Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematologic cancers or proliferative disorders. | 08-21-2008 |
20090023680 | Fixed ratio drug combination treatments for solid tumors - Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of irinotecan and floxuridine. Such methods are particularly useful in the treatment of cancer patients with advanced solid tumors. | 01-22-2009 |
20090068256 | Encapsulation of Bioactive Complexes in Liposomes - This invention provides a method to prepare liposome-encapsulated bioactive agents, such as nucleic acids, comprising complexation of the bioactive agents to reverse micelles prior to forming liposomes, as well as methods of using the liposomes so formed and formulations to deliver nucleic acids to cells. | 03-12-2009 |
20100189771 | FIXED RATIO DRUG COMBINATION TREATMENTS FOR SOLID TUMORS - Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of irinotecan and floxuridine. Such methods are particularly useful in the treatment of cancer patients with advanced solid tumors. | 07-29-2010 |
20100303895 | FIXED DRUG RATIOS FOR TREATMENT OF HEMATOPOIETIC CANCERS AND PROLIFERATIVE DISORDERS - Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematologic cancers or proliferative disorders. | 12-02-2010 |
Andrew S. Janoff, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20150060699 | AUTHENTICATION SYSTEMS EMPLOYING FLUORESCENT DIAMOND PARTICLES - Authentication systems for products employing populations containing particles of diamonds that have fluorescent emissions of various wavelengths, intensities and durations are described. By varying the populations of diamond particles in products to be labeled, multiple different identification systems can be obtained permitting authentication taggants for large numbers of different products. | 03-05-2015 |
Karen Janoff, Mt. Pleasant, SC US
Patent application number | Description | Published |
---|---|---|
20090270770 | Graphical patient movement monitor - A lack of patient movement monitor and method. The monitor and method patient support includes a plurality of sensors located beneath a patient support to determine movement of a patient. An alarm is activated when patient movement over time is determined to be lacking. | 10-29-2009 |
20100132116 | Patient Support with Orientation Sensitive Air Bladder Control - This disclosure describes a patient support having an air permeable layer, a plurality of inflatable bladders, a pressure-sensing assembly and a controller. In one embodiment, a combination of transverse bladders and vertically oriented can-shaped bladders is provided. In one embodiment, one or more angle sensors are provided in articulatable sections of the patient support. | 06-03-2010 |
Karen Janoff, Summerville, SC US
Patent application number | Description | Published |
---|---|---|
20140352074 | Patient Support with Air Bladder Control Sensitive to An Orientation Angle Sensor - A patient support includes a cover defining an interior region, an air permeable first layer located in the interior region, and a first air supply coupled to the first layer to provide air flow through the first layer. The patient support also includes a plurality of air bladders located beneath the air permeable first layer and a second air supply coupled to the air bladders to selectively inflate and deflate the air bladders. An angle sensor is located in the interior region in an articulatable portion of the patient support. A controller is coupled to the first and second air supplies and the angle sensor to control inflation and deflation of the air bladders in response to an angle signal received from the angle sensor and to control air flow through the air permeable layer in response to the angle signal. | 12-04-2014 |